Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations by Benjamin C. Park, Sathya Narayanan, Alexander Gavralidis, Fei Ye, Run Fan, Ryan J. Sullivan, Genevieve Boland, Kerry L Reynolds, Justin M. Balko, Matteo S. Carlino, Georgina V. Long, Leyre Zubiri, Alexander M. Menzies, Douglas B. Johnson

Subjects: Get full text

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs by Alisa Lepper, Rebekka Bitsch, Feyza Gül Özbay Kurt, Ihor Arkhypov, Samantha Lasser, Jochen Utikal, Viktor Umansky

Subjects: “…Immune-related adverse events…”
Get full text

Spontaneous haematoma: A unique immune-related adverse event alongside other cutaneous reactions in a patient treated with pembrolizumab for metastatic melanoma by Dalila Malek, Paul Gatt

Subjects: “…Immune related adverse events…”
Get full text

Enteritis of the ileal conduit as an adverse event related to immune checkpoint inhibitor use by Ko Kobayashi, Kohei Hashimoto, Toshiaki Tanaka, Naoya Masumori

Subjects: Get full text

Association of vitiligo with immune-checkpoint inhibitor therapy: A systematic review by Lauren Fleshner, MSc, Katie Roster, MD, Lillian Xie, BS, Shari R. Lipner, MD, PhD

Subjects: “…immune-related adverse events…”
Get full text

Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy by Haochuan Ma, Dili Song, Haibo Zhang, Taidong Li, Xing Jin

Subjects: Get full text

Cytokine release syndrome after treatment with immune checkpoint inhibitors: an observational cohort study of 2672 patients from Karolinska University Hospital in Sweden by Osama Hamida, Frans Karlsson, Andreas Lundqvist, Marco Gerling, Lisa L. Liu

Subjects: Get full text

Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs) by A Daban, C Gonnin, L Phan, A Saldmann, C Granier, A Lillo-Lelouet, C Le Beller, J Pouchot, l Weiss, E Tartour, E Fabre, J Medioni, S Oudard, YA Vano, MA Dragon-Durey, A. Simonaggio

Subjects: Get full text

Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma by I.A.J. van Duin, M. Schuiveling, L.S. ter Maat, M. Veta, M.J.M. van Eijs, R.J. Verheijden, F.W.P.J. van den Berkmortel, M.J. Boers-Sonderen, G.A.P. Hospers, M. Labots, J.W.B. de Groot, E. Kapiteijn, D. Piersma, G. Vreugdenhil, H. Westgeest, A.M.R. Schrader, P.J. van Diest, W.A.M. Blokx, K.P.M. Suijkerbuijk

Subjects: Get full text

EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapy by David Mao, Anne S. Reiner, Xi Chen, Jae Park, Martina Pennisi, Miguel-Angel Perales, Edward K. Avila, Bianca D. Santomasso

Subjects: Get full text

Establishment of an animal model of immune‐related adverse events induced by immune checkpoint inhibitors by Yuan Meng, Yingge Lv, Meng Shen, Wenwen Yu, Yumeng Liu, Ting Liu, Gen Liu, Shiya Ma, Zhenzhen Hui, Xiubao Ren, Liang Liu

Subjects: Get full text

Clinical characteristics of patients requiring emergency hospitalization due to immune-related adverse events: a retrospective study by Tatsuki Ikeda, Satoru Nihei, Kazuki Saito, Junichi Asaka, Kenzo Kudo

Subjects: Get full text

Analysis of the clinical efficacy and safety of anti‐PD‐1 immune checkpoint inhibitors in locally advanced nasopharyngeal cancer by Shuling Shi, Bingyan Li, Pengcheng Zhou, Linhui Chen, Huizhen Li, Yingyi Wang, Xiaoyu Deng, Qianqian Dang, Jingjing Wu, Boya Zha, Peihong Li, Yingjuan Zheng, Daoke Yang

Subjects: Get full text

Immune checkpoint inhibitor-induced diabetes mellitus: clinical characteristics and risk factors by Mei Zhan, Mei Zhan, Qinran Long, Qinran Long, Jinhan He, Jinhan He, Jinhan He, Litao Huang, Bin Wu, Bin Wu, Haixia Xu, Li Mo, Ting Xu

Subjects: Get full text

Clinical outcomes of endocrine and other disorders induced by immune checkpoint inhibitors in Japanese patients by Yuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto

Subjects: “…Immune-related adverse events…”
Get full text

Special immune-related adverse events and subsequent photodynamic therapy in tislelizumab treatment for esophageal cancer: a case report by Longzhao Li, Longzhao Li, Lingjie Bian, Na Kou, Yue Yuan, Heng Zou

Subjects: Get full text

Prediction-based prompt levothyroxine replacement to prevent a hypothyroid state after immune-related adverse events involving the thyroid gland by Ichiro Yamauchi, Takuro Hakata, Taku Sugawa, Daisuke Kosugi, Haruka Fujita, Kentaro Okamoto, Yohei Ueda, Toshihito Fujii, Daisuke Taura, Norio Harada, Nobuya Inagaki

Subjects: “…immune-related adverse events (iraes)…”
Get full text

Exfoliative esophagitis secondary to tislelizumab: a case report by Mingxing Wang, Qingming Sun, Wanhui Dong

Subjects: Get full text

Clinical characteristics and potential biomarkers of thyroid and pituitary immune-related adverse events by Tomoko Kobayashi, Shintaro Iwama, Hiroshi Arima

Subjects: Get full text

Delayed immune-related adverse events profile associated with immune checkpoint inhibitors: a real-world analysis by Yana Yang, Linman Li, Jing Tian, Linwen Ma, Yaoxin Wu, Qian Luo, Yan Luo

Subjects: Get full text